Summary
GlobalData's clinical trial report, “Huntington Disease Global Clinical Trials Review, H1, 2016" provides an overview of Huntington Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Pfizer Inc.
Teva Pharmaceutical Industries Limited
Medivation, Inc.
Prana Biotechnology Limited
Azevan Pharmaceuticals, Inc.
Siena Biotech S.p.A.
Omeros Corporation
Amarin Corporation Plc
GlaxoSmithKline Plc
A. Carlsson Research AB
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Huntington Disease to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Huntington Disease to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Huntington Disease Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Huntington Disease 30
Jan 11, 2016: Active Biotech: Information regarding the clinical study LEGATO-HD 30
Clinical Trial Profile Snapshots 31
Appendix 107
Abbreviations 107
Definitions 107
Research Methodology 108
Secondary Research 108
About GlobalData 109
Contact Us 109
Disclaimer 109
Source 110
List of Tables
Huntington Disease Therapeutics, Global, Clinical Trials by Region, 2016* 5
Huntington Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Huntington Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
Huntington Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Huntington Disease Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Huntington Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Huntington Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 13
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Huntington Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
Huntington Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Huntington Disease Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Huntington Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Huntington Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Huntington Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Huntington Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Huntington Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Huntington Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Huntington Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Huntington Disease Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Huntington Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Huntington Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9
Huntington Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Huntington Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Proportion of Huntington Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 13
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Huntington Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 16
Huntington Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Huntington Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Huntington Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Huntington Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Huntington Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Huntington Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Huntington Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Huntington Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Huntington Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 108
